Patient Buzz: Skin Bias in Dermatology
The New York Times is one of several major publications that have recently covered skin bias in dermatology. Is this coverage helpful or hurtful to the specialty? How can individual dermatologists make a difference in reducing disparities in care?
For their take, I reached out to Tiffany T. Mayo, MD, assistant professor of dermatology at the University of Alabama at Birmingham, and Theodore Ros …
The New York Times is one of several major publications that have recently covered skin bias in dermatology. Is this coverage helpful or hurtful to the specialty? How can individual dermatologists make a difference in reducing disparities in care?
For their take, I reached out to Tiffany T. Mayo, MD, assistant professor of dermatology at the University of Alabama at Birmingham, and Theodore Ros … 
The topic of disparities in the dermatologic care of skin of color is now receiving national attention in the consumer press. Articles in this month’s Patient Buzz address questions, including: Is skin bias in dermatology endangering people of color? Why are dermatology images not more diverse? What should Black patients know before their next dermatology visit?
Don’t be caught off guard wi … 
INTRODUCTION
Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic … 
Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia that is currently regarded as a variant of lichen planopilaris. FFA has historically been considered rare in black patients, in whom traction alopecia, central centrifugal cicatricial alopecia, and androgenetic alopecia are frequently assumed to be more common. JDD author Kimberly Huerth, MD, ME describes a case of FFA … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. John Harris, Vice-Chair of Dermatology and Director of the Vitiligo Clinic and Research Center at UMass Medical School in Worcester, Massachusetts, on new vitiligo treatments in the horizon. Watch as he shares recent discoveries that have influenced the way that we diagnose and manage pat … 